Test bBank bfor bIntroductory bClinical bPharmacology b12th bEdition
bFord
Introductory Clinical b
b Pharmacology 12th Edition Ford b b b
Test Bank b b
, Test bBank bfor bIntroductory bClinical bPharmacology b12th bEdition
bFord
1. A bnursing binstructor bis bpreparing ba bteaching bplan bfor ba bgroup bof bnursing bstudents
babout bpharmacology. bWhen bdescribing bthis btopic, bthe binstructor bwould bfocus bthe
bdiscussion bon bwhich bof bthe bfollowing bas ban bessential baspect?
A) Drug bname
B) Drug bclass
C) Drug baction
D) Drug bsource
bAns: b C
bFeedback:
Pharmacology bis bthe bstudy bof bdrugs band btheir baction bon bliving borganisms. bThus, ban
bessential baspect bof bpharmacology bis bdrug baction. bAn bunderstanding bof bthe bdrug bname,
bdrug bclass, band bdrug bsource bis bimportant, bbut bthe bmost bcritical baspect brelated bto
bpharmacology bis bhow bthe bdrug bacts bin bthe bbody.
2. A bnursing bstudent bis bpreparing bto badminister ba bprescribed bdrug bto ba bpatient. bThe
bstudent breviews binformation babout bthe bdrug band bits bactions. bWhich bof bthe bfollowing
bwould bbe bthe bbest bchoice bfor bobtaining bthis binformation? bSelect ball bthat bapply.
A) Nursing binstructor
B) Nurse bassigned bto bthe bpatient
C) Clinical bdrug breference
D) Prescribing bhealth bcare bprovider
E) Clinical bpharmacist
bAns: b C, bE
Feedback:
Although bthe bnursing bstudent bcan bask bthe bnursing binstructor, bthe bnurse bassigned bto bthe
bpatient, band bthe bprescribing bhealth bcare bprovider bfor binformation babout bthe bdrug, bthe
bbest bchoices bfor bdrug binformation bwould binclude ban bappropriate bdrug breference band
bthe bclinical bpharmacist.
3. When bdescribing bthe bvarious btypes bof bmedications bto ba bgroup bof bnursing bstudents,
ba bnursing binstructor bwould bidentify bwhich bof bthe bfollowing bas ba bsource bfor
bderiving bmedications? bSelect ball bthat bapply.
A) Plants
B) Synthetic bsources
C) Mold
D) Minerals
E) Animals
b Ans: b A, bB, bC, bD,
bE
Feedback:
Medications bare bderived bfrom bnatural bsources, bfor bexample, bplants, bmolds, bminerals,
band banimals, bas bwell bas bcreated bsynthetically bin ba blaboratory.
Page b 1
, Test bBank bfor bIntroductory bClinical bPharmacology b12th bEdition
bFord
4. Which bof bthe bfollowing bnames bmay bbe bassigned bto ba bdrug bduring bthe bprocess
bof bdevelopment? bSelect ball bthat bapply.
A) Chemical bname
B) Official bname
C) Pharmacologic bname
D) Trade bname
E) Nonproprietary bname
bAns: b A, bB, bD, bE
Feedback:
Throughout bthe bprocess bof bdevelopment, bdrugs bmay bhave bseveral bnames bassigned bto
bthem bincluding ba bchemical bname, ba bgeneric b(nonproprietary) bname, ban bofficial bname,
band ba btrade bor bbrand bname.
5. A bdrug bmay bbe bclassified bby bwhich bof bthe bfollowing? bSelect ball bthat bapply.
A) The bchemical btype bof bthe bdrug's bactive bingredient
B) The bway bthe bdrug bis bused bto btreat ba bspecific bcondition
C) The bgeneric bname bof bthe bdrug
D) The btrade bname bof bthe bdrug
E) The bnonproprietary bname bof bthe bdrug
bAns: b A, bB
Feedback:
A bdrug bmay bbe bclassified bby bthe bchemical btype bof bthe bactive bingredient bor bby bthe bway bit
bis bused bto btreat ba bparticular bcondition. bGeneric, btrade, band bnonproprietary brefer bto bhow
ba bdrug bis bnamed.
6. A bgroup bof bnursing bstudents bare breviewing binformation babout bthe bprocess bof bdrug
bdevelopment bin bthe bUnited bStates. bThe bstudents bdemonstrate bunderstanding bof bthis
bprocess bwhen bthey bidentify bthat bwhich bof bthe bfollowing bcategories bare bassigned bby
bthe bFood band bDrug bAdministration bto bnewly bapproved bdrugs? bSelect ball bthat bapply.
A) Metabolite
B) Noncontrolled bsubstance
C) Prescription
D) Nonprescription
E) Controlled bsubstance
bAns: b C, bD, bE
Feedback:
Once bdrugs bare bapproved bfor buse, bthe bFDA bassigns bthe bdrug bto bone bof bthe bfollowing
bcategories: bprescription, bnonprescription, bor bcontrolled bsubstance. bMetabolite brefers bto
bthe binactive bform bof bthe bdrug. bNoncontrolled bsubstance bis ba bterm bthat bis bnot bused.
Page b 2
, Test bBank bfor bIntroductory bClinical bPharmacology b12th bEdition
bFord
7. Which bof bthe bfollowing bwould bbe bmost bimportant bfor bthe bnurse bto bdo bto bensure bthe
bsafe buse bof bprescription bdrugs bin bthe binstitutional bsetting? bSelect ball bthat bapply.
A) Administering bdrugs
B) Monitoring bclients bfor bdrug beffects
C) Prescribing bdrugs
D) Evaluating bclients bfor btoxic beffects
E) Educating bclients/caregivers babout bdrugs
bAns: b A, bB, bD, bE
Feedback:
In bthe binstitutional bsetting, bthe bnurse's brole bto bensure bsafe buse bof bprescription bdrugs
bincludes badministering bdrugs, bmonitoring bdrug beffects, bevaluating bfor btoxic beffects, band
beducating bclients band bcaregivers babout bdrugs.
8. The bnurse bis bhelping ba bclient breview ba bprescription bfrom bthe bhealth bcare bprovider.
bWhen bexamining bthe bprescription, bwhich bof bthe bfollowing bwould bthe bnurse bexpect bto
bfind bdocumented? bSelect ball bthat bapply.
A) Name bof bthe bdrug
B) Dosage bof bthe bdrug
C) Route bof bdrug badministration
D) Times bof bdrug badministration
E) Licensed bprescriber's bsignature
bAns: b A, bB, bC, bD, bE
Feedback:
The bprescription bmust bcontain bthe bclient's bname, bthe bname bof bthe bdrug, bthe bdosage, bthe
bmethod band btimes bof badministration, band bthe bsignature bof bthe blicensed bhealth bcare
bprovider bprescribing bthe bdrug.
9. After bteaching ba bgroup bof bnursing bstudents babout bnonprescription bdrugs, bthe bnursing
binstructor bdetermines bthat bthe bteaching bwas bsuccessful bwhen bthe bstudents bidentify
bwhich bof bthe bfollowing? bSelect ball bthat bapply.
A) They brequire ba blicensed bhealth bcare bprovider's bsignature.
B) They bare breferred bto bas bover-the-counter bdrugs.
C) They bcan bbe btaken bwithout brisk bto bthe bclient.
D) They bhave bcertain blabeling brequirements.
E) They bshould bbe btaken bonly bas bdirected bon bthe
blabel. bAns: b B, bD, bE
Feedback:
Nonprescription bdrugs bare boften breferred bto bas bover-the-counter b(OTC) bdrugs. bThey bdo
bnot brequire ba bprescription b(a blicensed bhealth bcare bprovider's bsignature) bbut bdo bnot
bcome bwithout brisk bto bthe bclient. bThe bfederal bgovernment bhas bimposed blabeling
brequirements bof bOTC bdrugs band bthey bshould bonly bbe btaken bas bdirected bon bthe blabel
bunless bunder bthe bsupervision bof ba bhealth bcare bprovider.
Page b 3
bFord
Introductory Clinical b
b Pharmacology 12th Edition Ford b b b
Test Bank b b
, Test bBank bfor bIntroductory bClinical bPharmacology b12th bEdition
bFord
1. A bnursing binstructor bis bpreparing ba bteaching bplan bfor ba bgroup bof bnursing bstudents
babout bpharmacology. bWhen bdescribing bthis btopic, bthe binstructor bwould bfocus bthe
bdiscussion bon bwhich bof bthe bfollowing bas ban bessential baspect?
A) Drug bname
B) Drug bclass
C) Drug baction
D) Drug bsource
bAns: b C
bFeedback:
Pharmacology bis bthe bstudy bof bdrugs band btheir baction bon bliving borganisms. bThus, ban
bessential baspect bof bpharmacology bis bdrug baction. bAn bunderstanding bof bthe bdrug bname,
bdrug bclass, band bdrug bsource bis bimportant, bbut bthe bmost bcritical baspect brelated bto
bpharmacology bis bhow bthe bdrug bacts bin bthe bbody.
2. A bnursing bstudent bis bpreparing bto badminister ba bprescribed bdrug bto ba bpatient. bThe
bstudent breviews binformation babout bthe bdrug band bits bactions. bWhich bof bthe bfollowing
bwould bbe bthe bbest bchoice bfor bobtaining bthis binformation? bSelect ball bthat bapply.
A) Nursing binstructor
B) Nurse bassigned bto bthe bpatient
C) Clinical bdrug breference
D) Prescribing bhealth bcare bprovider
E) Clinical bpharmacist
bAns: b C, bE
Feedback:
Although bthe bnursing bstudent bcan bask bthe bnursing binstructor, bthe bnurse bassigned bto bthe
bpatient, band bthe bprescribing bhealth bcare bprovider bfor binformation babout bthe bdrug, bthe
bbest bchoices bfor bdrug binformation bwould binclude ban bappropriate bdrug breference band
bthe bclinical bpharmacist.
3. When bdescribing bthe bvarious btypes bof bmedications bto ba bgroup bof bnursing bstudents,
ba bnursing binstructor bwould bidentify bwhich bof bthe bfollowing bas ba bsource bfor
bderiving bmedications? bSelect ball bthat bapply.
A) Plants
B) Synthetic bsources
C) Mold
D) Minerals
E) Animals
b Ans: b A, bB, bC, bD,
bE
Feedback:
Medications bare bderived bfrom bnatural bsources, bfor bexample, bplants, bmolds, bminerals,
band banimals, bas bwell bas bcreated bsynthetically bin ba blaboratory.
Page b 1
, Test bBank bfor bIntroductory bClinical bPharmacology b12th bEdition
bFord
4. Which bof bthe bfollowing bnames bmay bbe bassigned bto ba bdrug bduring bthe bprocess
bof bdevelopment? bSelect ball bthat bapply.
A) Chemical bname
B) Official bname
C) Pharmacologic bname
D) Trade bname
E) Nonproprietary bname
bAns: b A, bB, bD, bE
Feedback:
Throughout bthe bprocess bof bdevelopment, bdrugs bmay bhave bseveral bnames bassigned bto
bthem bincluding ba bchemical bname, ba bgeneric b(nonproprietary) bname, ban bofficial bname,
band ba btrade bor bbrand bname.
5. A bdrug bmay bbe bclassified bby bwhich bof bthe bfollowing? bSelect ball bthat bapply.
A) The bchemical btype bof bthe bdrug's bactive bingredient
B) The bway bthe bdrug bis bused bto btreat ba bspecific bcondition
C) The bgeneric bname bof bthe bdrug
D) The btrade bname bof bthe bdrug
E) The bnonproprietary bname bof bthe bdrug
bAns: b A, bB
Feedback:
A bdrug bmay bbe bclassified bby bthe bchemical btype bof bthe bactive bingredient bor bby bthe bway bit
bis bused bto btreat ba bparticular bcondition. bGeneric, btrade, band bnonproprietary brefer bto bhow
ba bdrug bis bnamed.
6. A bgroup bof bnursing bstudents bare breviewing binformation babout bthe bprocess bof bdrug
bdevelopment bin bthe bUnited bStates. bThe bstudents bdemonstrate bunderstanding bof bthis
bprocess bwhen bthey bidentify bthat bwhich bof bthe bfollowing bcategories bare bassigned bby
bthe bFood band bDrug bAdministration bto bnewly bapproved bdrugs? bSelect ball bthat bapply.
A) Metabolite
B) Noncontrolled bsubstance
C) Prescription
D) Nonprescription
E) Controlled bsubstance
bAns: b C, bD, bE
Feedback:
Once bdrugs bare bapproved bfor buse, bthe bFDA bassigns bthe bdrug bto bone bof bthe bfollowing
bcategories: bprescription, bnonprescription, bor bcontrolled bsubstance. bMetabolite brefers bto
bthe binactive bform bof bthe bdrug. bNoncontrolled bsubstance bis ba bterm bthat bis bnot bused.
Page b 2
, Test bBank bfor bIntroductory bClinical bPharmacology b12th bEdition
bFord
7. Which bof bthe bfollowing bwould bbe bmost bimportant bfor bthe bnurse bto bdo bto bensure bthe
bsafe buse bof bprescription bdrugs bin bthe binstitutional bsetting? bSelect ball bthat bapply.
A) Administering bdrugs
B) Monitoring bclients bfor bdrug beffects
C) Prescribing bdrugs
D) Evaluating bclients bfor btoxic beffects
E) Educating bclients/caregivers babout bdrugs
bAns: b A, bB, bD, bE
Feedback:
In bthe binstitutional bsetting, bthe bnurse's brole bto bensure bsafe buse bof bprescription bdrugs
bincludes badministering bdrugs, bmonitoring bdrug beffects, bevaluating bfor btoxic beffects, band
beducating bclients band bcaregivers babout bdrugs.
8. The bnurse bis bhelping ba bclient breview ba bprescription bfrom bthe bhealth bcare bprovider.
bWhen bexamining bthe bprescription, bwhich bof bthe bfollowing bwould bthe bnurse bexpect bto
bfind bdocumented? bSelect ball bthat bapply.
A) Name bof bthe bdrug
B) Dosage bof bthe bdrug
C) Route bof bdrug badministration
D) Times bof bdrug badministration
E) Licensed bprescriber's bsignature
bAns: b A, bB, bC, bD, bE
Feedback:
The bprescription bmust bcontain bthe bclient's bname, bthe bname bof bthe bdrug, bthe bdosage, bthe
bmethod band btimes bof badministration, band bthe bsignature bof bthe blicensed bhealth bcare
bprovider bprescribing bthe bdrug.
9. After bteaching ba bgroup bof bnursing bstudents babout bnonprescription bdrugs, bthe bnursing
binstructor bdetermines bthat bthe bteaching bwas bsuccessful bwhen bthe bstudents bidentify
bwhich bof bthe bfollowing? bSelect ball bthat bapply.
A) They brequire ba blicensed bhealth bcare bprovider's bsignature.
B) They bare breferred bto bas bover-the-counter bdrugs.
C) They bcan bbe btaken bwithout brisk bto bthe bclient.
D) They bhave bcertain blabeling brequirements.
E) They bshould bbe btaken bonly bas bdirected bon bthe
blabel. bAns: b B, bD, bE
Feedback:
Nonprescription bdrugs bare boften breferred bto bas bover-the-counter b(OTC) bdrugs. bThey bdo
bnot brequire ba bprescription b(a blicensed bhealth bcare bprovider's bsignature) bbut bdo bnot
bcome bwithout brisk bto bthe bclient. bThe bfederal bgovernment bhas bimposed blabeling
brequirements bof bOTC bdrugs band bthey bshould bonly bbe btaken bas bdirected bon bthe blabel
bunless bunder bthe bsupervision bof ba bhealth bcare bprovider.
Page b 3
